A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Clinical trial NCT04096560 · TERMINATED

Trial details

NCT number: NCT04096560
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Narcolepsy Type 1 (NT1)Narcolepsy Type 2 (NT2)

Start date: 2020-05-27
Primary completion: 2021-11-05
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.